Results 301 to 310 of about 3,568,234 (327)

Hepatosplenic T‐cell lymphoma, immunosuppressive agents and biologicals: what are the risks?

Internal medicine journal (Print), 2014
K. Subramaniam, D. Yeung, F. Grimpen, J. Joseph, K. Fay, M. Buckland, D. Talaulikar, J. Elijah, A. C. Clarke, P. Pavli, J. Moore   +10 more
semanticscholar   +1 more source

Immunosuppressive Agents

2006
openaire   +2 more sources

The current state of molecular testing in the treatment of patients with solid tumors, 2019

Ca-A Cancer Journal for Clinicians, 2019
Wafik S El-Deiry, Richard M Goldberg, Heinz-Josef Lenz   +2 more
exaly  

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review

British Journal of Dermatology, 2013
J. Blok, S. V. Hattem, M. Jonkman, B. Horváth   +3 more
semanticscholar   +1 more source

Targeting immunosuppressive adenosine in cancer

Nature Reviews. Cancer, 2017
Dipti Vijayan, A. Young, M. Teng, M. Smyth   +3 more
semanticscholar   +1 more source

Immunosuppressive Agents

1982
M. M. Sigel, A. Ghaffar, L. J. Mc Cumber, E. M. Huggins   +3 more
openaire   +1 more source

Anti-inflammatory and immunosuppressive agents in PAH.

Handbook of Experimental Pharmacology, 2013
J. Meloche, S. Renard, S. Provencher, S. Bonnet   +3 more
semanticscholar   +1 more source

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly